{"title":"镰状细胞病的表型:帮助识别意大利景观中未确诊患者的策略。","authors":"Maddalena Casale, Silvia Benemei, Cristiano Gallucci, Giovanna Graziadei, Giovanni Battista Ferrero","doi":"10.1186/s13052-025-01992-y","DOIUrl":null,"url":null,"abstract":"<p><p>Sickle cell disease (SCD) is an inherited autosomal recessive monogenic blood disorder characterized by red blood cell sickling responsible for recurrent vaso-occlusive crises and chronic hemolysis. Clinical manifestations vary and SCD patients experience increased morbidity and mortality. In Italy, SCD patients cluster into two distinct subpopulations: those of sub-Saharan African descent and those of Caucasian descent. Most sub-Saharan African SCD patients are children or young adults and carry the homozygous genotype hemoglobin (Hb) S, or SC, whereas Caucasian SCD patients tend to be older and have predominantly HbS/β-thalassemia. Patients of African descent typically present with acute SCD-related events, including vaso-occlusive crises, acute chest syndrome, anemia, fever, and pneumonia. Caucasian patients, according to the different distribution of SCD genotypes, may exhibit either acute episodes or chronic long-term complications. Regardless of age, genotype, or ethnic background, most SCD patients in Italy are undiagnosed, and pain, fatigue and anemia should be regarded as presenting signs and symptoms of this disease. The tests needed to diagnose SCD are simple, and a complete blood count together with erythrocyte morphology, wherever available, hemolysis markers, should be performed whenever SCD is suspected. If a patient presents with two risk factors -family history, ethnicity, or a significant clinical feature - a first-level screening test (e.g. assessment of Hb fractions with HPLC), where available, should be performed immediately, or a referral should be provided. Here, we present an overview of the clinical features of SCD that may be encountered in real-world clinical practice in Italy from a practical perspective. This narrative review may aid non-specialist physicians in identifying disparate clinical conditions that may be symptoms or signs of SCD.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"157"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121258/pdf/","citationCount":"0","resultStr":"{\"title\":\"The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.\",\"authors\":\"Maddalena Casale, Silvia Benemei, Cristiano Gallucci, Giovanna Graziadei, Giovanni Battista Ferrero\",\"doi\":\"10.1186/s13052-025-01992-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Sickle cell disease (SCD) is an inherited autosomal recessive monogenic blood disorder characterized by red blood cell sickling responsible for recurrent vaso-occlusive crises and chronic hemolysis. Clinical manifestations vary and SCD patients experience increased morbidity and mortality. In Italy, SCD patients cluster into two distinct subpopulations: those of sub-Saharan African descent and those of Caucasian descent. Most sub-Saharan African SCD patients are children or young adults and carry the homozygous genotype hemoglobin (Hb) S, or SC, whereas Caucasian SCD patients tend to be older and have predominantly HbS/β-thalassemia. Patients of African descent typically present with acute SCD-related events, including vaso-occlusive crises, acute chest syndrome, anemia, fever, and pneumonia. Caucasian patients, according to the different distribution of SCD genotypes, may exhibit either acute episodes or chronic long-term complications. Regardless of age, genotype, or ethnic background, most SCD patients in Italy are undiagnosed, and pain, fatigue and anemia should be regarded as presenting signs and symptoms of this disease. The tests needed to diagnose SCD are simple, and a complete blood count together with erythrocyte morphology, wherever available, hemolysis markers, should be performed whenever SCD is suspected. If a patient presents with two risk factors -family history, ethnicity, or a significant clinical feature - a first-level screening test (e.g. assessment of Hb fractions with HPLC), where available, should be performed immediately, or a referral should be provided. Here, we present an overview of the clinical features of SCD that may be encountered in real-world clinical practice in Italy from a practical perspective. This narrative review may aid non-specialist physicians in identifying disparate clinical conditions that may be symptoms or signs of SCD.</p>\",\"PeriodicalId\":14511,\"journal\":{\"name\":\"Italian Journal of Pediatrics\",\"volume\":\"51 1\",\"pages\":\"157\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-05-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12121258/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Italian Journal of Pediatrics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13052-025-01992-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Italian Journal of Pediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13052-025-01992-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PEDIATRICS","Score":null,"Total":0}
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.
Sickle cell disease (SCD) is an inherited autosomal recessive monogenic blood disorder characterized by red blood cell sickling responsible for recurrent vaso-occlusive crises and chronic hemolysis. Clinical manifestations vary and SCD patients experience increased morbidity and mortality. In Italy, SCD patients cluster into two distinct subpopulations: those of sub-Saharan African descent and those of Caucasian descent. Most sub-Saharan African SCD patients are children or young adults and carry the homozygous genotype hemoglobin (Hb) S, or SC, whereas Caucasian SCD patients tend to be older and have predominantly HbS/β-thalassemia. Patients of African descent typically present with acute SCD-related events, including vaso-occlusive crises, acute chest syndrome, anemia, fever, and pneumonia. Caucasian patients, according to the different distribution of SCD genotypes, may exhibit either acute episodes or chronic long-term complications. Regardless of age, genotype, or ethnic background, most SCD patients in Italy are undiagnosed, and pain, fatigue and anemia should be regarded as presenting signs and symptoms of this disease. The tests needed to diagnose SCD are simple, and a complete blood count together with erythrocyte morphology, wherever available, hemolysis markers, should be performed whenever SCD is suspected. If a patient presents with two risk factors -family history, ethnicity, or a significant clinical feature - a first-level screening test (e.g. assessment of Hb fractions with HPLC), where available, should be performed immediately, or a referral should be provided. Here, we present an overview of the clinical features of SCD that may be encountered in real-world clinical practice in Italy from a practical perspective. This narrative review may aid non-specialist physicians in identifying disparate clinical conditions that may be symptoms or signs of SCD.
期刊介绍:
Italian Journal of Pediatrics is an open access peer-reviewed journal that includes all aspects of pediatric medicine. The journal also covers health service and public health research that addresses primary care issues.
The journal provides a high-quality forum for pediatricians and other healthcare professionals to report and discuss up-to-the-minute research and expert reviews in the field of pediatric medicine. The journal will continue to develop the range of articles published to enable this invaluable resource to stay at the forefront of the field.
Italian Journal of Pediatrics, which commenced in 1975 as Rivista Italiana di Pediatria, provides a high-quality forum for pediatricians and other healthcare professionals to report and discuss up-to-the-minute research and expert reviews in the field of pediatric medicine. The journal will continue to develop the range of articles published to enable this invaluable resource to stay at the forefront of the field.